Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors

Elissa A S Polomski1, Julius C Heemelaar1, Augustinus D G Krol2

  • 1Department of Cardiology, Heart Lung Center, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Cancers
|May 14, 2022
PubMed

Insights

Thoracic irradiation for classic Hodgkin lymphoma (CHL) survivors increases cardiovascular risks. Impaired left ventricular (LV) function, particularly global longitudinal strain (GLS), is linked to cardiac events and death.

Area of Science:

  • Cardiology
  • Oncology
  • Radiotherapy

Background:

  • Thoracic irradiation for classic Hodgkin lymphoma (CHL) improves survival but elevates cardiovascular event risk.
  • Left ventricular ejection fraction (LVEF) assesses LV function, while global longitudinal strain (GLS) detects early subclinical dysfunction.

Purpose of the Study:

  • To determine if conventional echocardiographic parameters and GLS predict cardiovascular events in CHL survivors.
  • To evaluate the association between LV dysfunction and long-term cardiac outcomes post-radiotherapy.

Main Methods:

  • 129 CHL patients treated with radiotherapy, with echocardiography >10 years post-diagnosis, were analyzed.
  • Multivariable Cox regression assessed the composite endpoint of cardiac death/cardiovascular events and competing noncardiac death.
  • Echocardiographic parameters including GLS, LVEF, and E/e’ were evaluated.

Main Results:

  • Impaired GLS (> -16%) was significantly associated with a nearly four-fold increased risk of cardiac events (HR=3.95, p<0.001).
  • Reduced LVEF (<50%) (HR=2.99, p=0.016) and elevated E/e’ (HR=1.16, p<0.001) also predicted adverse outcomes.
  • No assessed parameters correlated with noncardiac death.

Conclusions:

  • Left ventricular dysfunction, including impaired GLS, is a significant predictor of cardiovascular events and cardiac death in CHL survivors.
  • Echocardiographic parameters like GLS and LVEF are crucial for risk stratification in this patient population.
  • Long-term cardiac monitoring is essential for CHL survivors treated with thoracic irradiation.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
71
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
83
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
49
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
262